2022-07-27 | NDAQ:ATNF | Press Release | 180 Life Sciences C

(2022-07-27 | NDAQ:ATNF) 180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program With 180 Life Sciences Corp.

Related Keywords

United Kingdom , United States , Clin Anesth , Marc Feldmann , David Schull , Jason Assad , Life Sciences Closecurlyquote , Company Closecurlydoublequote , Nasdaq , Agency For Healthcare , Company Closecurlyquote , Department Of Health , Research Quality , Life Sciences Closecurlydoublequote , Celltrion Healthcare United Kingdom , Research For Patient Benefit Rfpb Programme , University Of Oxford , Life Sciences Corp , National Institute For Health , Exchange Commission , Kennedy Trust For Rheumatology Research , Life Sciences , Care Research , Sciences Closecurlydoublequote , National Institute , World Hip Trauma Evaluation , Cognitive Impairment , Patient Benefit , Jim Woody , Kennedy Trust , Sir Marc Feldmann , Matt Costa , Professor Nanchahal , United Kingdom Aid , Private Securities Litigation Reform Act , Science Closecurlyquote , Sciences Closecurlyquote , Investigational New Drug , Annual Report , Quarterly Report , Sciences Corp , 180 Life Sciences Corp , Healthcare 37 , Biotechnology 121 , Usa 8 , Biotechnology 70569 ,